6533b82efe1ef96bd129340f

RESEARCH PRODUCT

Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017.

Simona AttardoGiuseppe CabibboGiampaolo BresciLuca GiacomelliAurora MirabileRodolfo Sacco

subject

OncologyCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularAntineoplastic AgentsHepacivirusGastroenterologyAntiviral Agents03 medical and health sciences0302 clinical medicineInternal medicinemedicineAdvanced diseaseHumansNeoplasm StagingHepatitis c viralgeographyClinical Trials as TopicSummitgeography.geographical_feature_categorybusiness.industryLiver NeoplasmsGeneral MedicineCongresses as TopicHepatitis C Chronicmedicine.diseasePrognosisCombined Modality Therapydigestive system diseasesClinical researchOncologyLiver030220 oncology & carcinogenesisHepatocellular carcinomaEarly hccCatheter AblationDisease Progression030211 gastroenterology & hepatologybusinessSwitzerland

description

The European Association for the Study of the Liver Hepatocellular Carcinoma (HCC) international meeting held in Geneva in February 2017 focused on the state of the art of HCC management, from diagnosis to treatment and the potential development of clinical research in this field. This report reviews some of the most interesting topics discussed at the meeting such as the role of hepatitis C viral infection treatment with direct-acting antivirals in enhancing HCC risk, current prognostic systems, early diagnosis techniques, curative therapies for early HCC and the systemic treatments for advanced disease with a look into future perspectives.

yearjournalcountryeditionlanguage
2017-06-08Future oncology (London, England)
10.2217/fon-2017-0133https://pubmed.ncbi.nlm.nih.gov/28589772